Compound Detail

CHEMBL4533824

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CC(=O)Nc1ccc(S(=O)(=O)N2C/C(=C\c3cccnc3)C(=O)/C(=C/c3ccccc3C(F)(F)F)C2)cc1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4533824
Phase	Preclinical
Structure Type	MOL
InChI Key	CSXYNYSNLQBGOF-JFMUQQRKSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

541.5

MW (Da)

4.80

ALogP

HBA

HBD

96.4

PSA (Å²)

0.47

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 4 meas. best 5.36

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HepG2 CHEMBL395	IC50	5.36	5.36	4330.0	1
QGY-7703 CHEMBL4296490	IC50	5.27	5.27	5380.0	1
SMMC-7721 CHEMBL613831	IC50	5.01	5.01	9830.0	1
L02 CHEMBL4296457	IC50	4.82	4.82	15290.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HepG2	IC50	=	4330.0	nM	5.36	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability i...	30771605
QGY-7703	IC50	=	5380.0	nM	5.27	Cytotoxicity against human QGY7703 cells assessed as reduction in cell viability...	30771605
SMMC-7721	IC50	=	9830.0	nM	5.01	Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viabilit...	30771605
L02	IC50	=	15290.0	nM	4.82	Cytotoxicity against human LO2 cells assessed as reduction in cell viability inc...	30771605

PubMed	DOI	Target Context	# Activities
30771605	10.1016/j.ejmech.2019.02.020	RAW264.7	3
30771605	10.1016/j.ejmech.2019.02.020	HepG2	1
30771605	10.1016/j.ejmech.2019.02.020	QGY-7703	1
30771605	10.1016/j.ejmech.2019.02.020	SMMC-7721	1
30771605	10.1016/j.ejmech.2019.02.020	Unchecked	1
30771605	10.1016/j.ejmech.2019.02.020	L02	1

Data from ChEMBL 36 via Core Engine